Literature DB >> 4395890

A new approach to the study of serum concentrations of orally administered cephalexin.

C H O'Callaghan, J P Tootill, W D Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4395890     DOI： 10.1111/j.2042-7158.1971.tb12779.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Irreversible effects of serum proteins on beta-lactam antibiotics.

Authors:  C H O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

Review 3.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Absorption and excretion of cephalexin by the newborn infant.

Authors:  R Boothman; M M Kerr; M J Marshall; W L Burland
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

5.  Absorption and excretion of cephalexin in health and acute illness.

Authors:  S Dean; L K Harding; R Wise; N Wright
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

6.  The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates.

Authors:  S M Harding; P B Harper
Journal:  Infection       Date:  1983       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.